Capricor Therapeutics, Inc

(NASDAQ:CAPR)

Latest On Capricor Therapeutics, Inc (CAPR):

Date/Time Type Description Signal Details
2023-05-12 07:12 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 17:36 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 18:00 ESTNewsCapricor Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-25 14:41 ESTNewsCapricor stock falls amid data for duchenne muscular dystrophy studyN/A
2022-11-11 07:18 ESTNewsCapricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45MN/A
2022-11-11 07:17 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 21:36 ESTNewsCapricor Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-12 00:03 ESTNewsCapricor stock rises 16% after update on muscular dystrophy treatment, Q2 resultsN/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics GAAP EPS of -$0.29 misses by $0.03N/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2022 Results Earnings Call TranscriptN/A
2022-08-09 20:06 ESTNewsCapricor Therapeutics Q2 Earnings PreviewN/A
2022-06-28 01:00 ESTNewsCapricor posts statistically significant data for DMD candidate in open-label trialN/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics GAAP EPS of -$0.32N/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-28 16:40 ESTNewsCapricor Therapeutics down 24% following COVID-19 mid-stage trial results (updated)N/A
2022-03-11 08:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban On Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-25 10:04 ESTNewsCapricor jumps 12% after CAP-1002 commercialization deal in U.S. for treatment of DMDN/A
2021-12-13 16:39 ESTNewsCapricor Therapeutics provides key updates on its COVID-19 vaccine programsN/A
2021-11-10 04:09 ESTNewsCapricor Therapeutics EPS beats by $0.06N/A
2021-11-10 04:08 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 05:10 ESTNewsCapricor Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-25 19:24 ESTNewsCapricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial ResultN/A
2021-09-24 23:37 ESTNewsCapricor jumps 17% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy studyN/A
2021-09-02 16:11 ESTNewsCapricor shares up 6 % as it will present final data on muscular dystrophy candidate late SeptemberN/A
2021-08-13 10:16 ESTNewsCapricor Therapeutics EPS beats by $0.02, misses on revenueN/A
2021-08-13 10:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-20 22:51 ESTNewsCapricor Therapeutics slumps 9% on $75M stock offeringN/A
2021-04-30 07:24 ESTNewsCapricor shares rise on license agreement with Johns Hopkins UniversityN/A
2021-03-18 04:19 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 03:16 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:18 ESTEarnings EstimateAn EPS average of -$1.07 is estimated for the 2022 year.Sell
2021-03-12 00:43 ESTNewsCapricor Therapeutics EPS misses by $0.01N/A
2021-03-12 00:43 ESTNewsCapricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-09 13:49 ESTNewsCapricor Therapeutics updates on COVID-19 vaccine pre-clinical studyN/A
2021-02-10 08:09 ESTNewsCapricor Therapeutics - Shockingly Undervalued With Imminent Catalysts In PlayN/A
2021-02-01 10:47 ESTNewsCapricor signs intellectual property license for COVID-19 serology test platformN/A
2021-01-25 03:17 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $12.Buy
2021-01-20 01:02 ESTNewsCapricor announces positive findings from collaboration with Cedars-Sinai Medical Center researchersN/A
2021-01-12 20:54 ESTNewsCapricor and Lonza tie up in DMD developmentN/A
2020-12-13 03:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:54 ESTNewsDosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19N/A
2020-11-18 03:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:56 ESTNewsCapricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-12 19:06 ESTNewsCapricor Therapeutics reports Q3 resultsN/A
2020-11-01 17:26 ESTFinancialsCompany financials have been released.Neutral

About Capricor Therapeutics, Inc (CAPR):

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002, a cardiac cell derived therapy, which is in phase II clinical trial for the treatment of patients with late-stage DMD; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of inflammatory conditions. Capricor collaborates with Lonza for the development of CAP-1002, its cell therapy candidate for the treatment of Duchenne muscular dystrophy and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

See Advanced Chart

General

  • Name Capricor Therapeutics, Inc
  • Symbol CAPR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:10
  • Last Split Date2019-06-05
  • Fiscal Year EndDecember
  • IPO Date2007-02-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.capricor.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 149.52
  • Price/Book (Most Recent Quarter) 4.13
  • Enterprise Value Revenue 190.86
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.00
  • Next Year EPS Estimate -$1.06
  • Operating Margin -4413%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 310250
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.02
  • Gross Profit -8146750
  • Quarterly Earnings Growth -74%
View More

Highlights

  • Market Capitalization 118.78 million
  • EBITDA -11929662
  • Analyst Target Price $12
  • Book Value Per Share $1.37
View More

Share Statistics

  • Shares Outstanding 22.8 million
  • Shares Float 19.99 million
  • % Held by Insiders 253%
  • % Held by Institutions 6.2%
  • Shares Short 345150
  • Shares Short Prior Month 489136
  • Short Ratio 0.36
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 6.47
  • 52 Week High $12.32
  • 52 Week Low $0.96
  • 50 Day Moving Average 6.37
  • 200 Day Moving Average 5.05
View More

Dividends

  • Dividend Date 2019-06-05
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Capricor Therapeutics, Inc (CAPR) Dividend Calendar:

CAPR's last dividend payment was made to shareholders on June 5, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Capricor Therapeutics, Inc (CAPR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.21-$0.20-5%
2020-09-302020-11-12$N/A-$0.20-$0.3745.95%
2020-06-302020-08-06$N/A-$0.23-$0.3432.35%
2020-03-312020-05-13$185693-$0.30-$0.3616.67%
2019-12-312020-03-18$222100-$0.34-$0.340%
2019-09-302019-11-07$142071-$0.43-$0.6836.76%
2019-06-302019-08-06$410353-$0.59-$0.8026.25%
2019-03-312019-05-13$230504-$0.80-$1.1027.27%
2018-12-312019-03-28$648082-$1.10-$1.6031.25%
2018-09-302018-11-13$219247-$1.40-$1.453.45%
2018-06-302018-08-09$403960-$1.40-$1.25-12%
2018-03-312018-05-10$400066-$1.40-$1.20-16.67%
2017-12-312018-03-14$475000$4.20-$1.00520%
2017-09-302017-11-08$314000-$1.20-$1.9036.84%
2017-06-302017-08-10$996000-$1.60-$1.8011.11%
2017-03-312017-05-15$881000-$1.70-$1.50-13.33%
2016-12-312017-03-15$907000-$2.10-$2.7022.22%
2016-09-302016-11-10$747000-$2.90-$2.65-9.43%
2016-06-302016-08-15$1.13 million-$2.60-$2.40-8.33%
2016-03-312016-05-12$1.22 million-$2.60-$1.90-36.84%
2015-12-312016-03-17$1.12 million-$2.10-$1.90-10.53%
2015-09-302015-11-12$1.32 million-$0.18-$0.2630.77%
2015-06-302015-08-13$1.29 million-$0.19-$0.2626.92%
2015-03-312015-05-12$1.79 million-$0.23-$0.14-64.29%
2014-12-312015-03-16$1.4 million-$0.16-$0.13-23.08%
2014-09-302014-11-14$1.3 million-$0.13-$0.2240.91%
2014-06-302014-08-14$1.04 million-$1.31
2014-03-312014-05-15$1.04 million-$1.04
2013-12-312014-03-17$503233-$6.39
2013-09-302013-11-15$80000-$4.02
2013-06-302013-08-15$190000-$6.94
2013-03-312013-06-21$233000-$5.61
2012-12-312013-03-12$2.03 million-$2.39
2012-09-302012-11-12$-2423235-$6.57
2012-06-302012-08-13$N/A-$4.11
2012-03-312012-05-15$195500-$20.00-$15.00-33.33%
2011-12-312012-03-13-$22.29
2011-09-302011-11-14$813000-$15.00-$7.50-100%
2011-06-302011-08-15$346000-$15.00-$5.00-200%
2011-03-312011-05-16-$15.00-$10.00-50%
2010-12-312011-03-14-$10.00-$21.6753.85%
2010-09-302010-11-12-$25.00-$23.33-7.16%
2010-06-302010-08-16-$25.00-$33.3324.99%
2010-03-312010-05-14-$35.00-$28.33-23.54%
2009-12-312010-03-03-$30.00-$25.00-20%
2009-09-302009-11-12-$40.00-$25.00-60%
2009-06-302009-08-13-$50.00-$37.50-33.33%
2009-03-312009-05-14-$35.00-$58.3340%
2008-12-312009-03-09-$60.00-$65.007.69%
2008-09-302008-11-13-$70.00-$78.3310.63%
2008-06-302008-08-14-$80.00-$57.50-39.13%
2008-03-312008-05-15-$65.00-$55.00-18.18%
2007-12-312008-03-13-$50.00-$95.0047.37%
2007-09-302007-11-28-$173.63
2006-12-312006-12-31-$6.69
2006-09-302006-09-30-$23.16
2006-06-302006-06-30-$5.98
2006-03-312006-03-31-$4.79
2005-09-302005-09-30-$2.28
2005-06-302005-06-30-$1.95
2005-03-312005-03-31-$3.57
2004-12-312004-12-31-$6.14
2004-09-302004-09-30-$2.33
2004-06-302004-06-30-$1.90
2004-03-312004-03-31-$1.64
2003-12-312003-12-31-$3.57
2003-09-302003-09-30-$0.06
2003-06-302003-06-30-$4.61
2003-03-312003-03-31-$2.46
2002-12-312002-12-31-$2.50
2002-09-302002-09-30-$5.67
2002-06-302002-06-30-$6.25

Capricor Therapeutics, Inc (CAPR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Capricor Therapeutics, Inc (CAPR) Chart:

Capricor Therapeutics, Inc (CAPR) News:

Below you will find a list of latest news for Capricor Therapeutics, Inc (CAPR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Capricor Therapeutics, Inc (CAPR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-192.55.4CALL0 5241.58TRUE00
2025-09-1952.25CALL10 365100.79TRUE0.150.07
2025-09-197.50.73CALL77 7296116.17FALSE0.080.12
2025-09-19100.25CALL72 5388125.94FALSE00
2025-09-1912.50.15CALL0 3626154.44FALSE00
2025-09-19150.1CALL205 6647164.36FALSE-0.01-0.09
2025-09-1917.50.05CALL0 479260.4FALSE00
2025-09-19200.08CALL30 4199199.61FALSE0.010.14
2025-09-1922.50.05CALL30 468200.39FALSE00
2025-09-19250.04CALL0 3048314.42FALSE00
2025-09-19300.02CALL0 3077264.17FALSE00
2025-09-192.50.03PUT10 5766200.2FALSE-0.02-0.4
2025-09-1950.25PUT154 4158140.8FALSE0.050.25
2025-09-197.51.25PUT2655 7806123.57TRUE-0.05-0.04
2025-09-19103.35PUT3 7518149.28TRUE0.050.02
2025-09-1912.55.3PUT0 2578169.7TRUE00
2025-09-19158.1PUT0 517162.55TRUE00
2025-09-1917.510.9PUT0 74187.37TRUE00
2025-09-192014PUT0 75275.57TRUE00
2025-09-1922.50PUT0 8365.65TRUE00
2025-09-192516.9PUT0 17368.33TRUE00
2025-09-193022.1PUT0 45399.28TRUE00
2025-10-172.50CALL0 0168.21TRUE00
2025-10-1752.3CALL0 1297.2TRUE00
2025-10-177.51.25CALL743 57129.16FALSE0.20.19
2025-10-17100.7CALL2407 4137.26FALSE0.70
2025-10-1712.50.5CALL0 19121.16FALSE00
2025-10-17150CALL0 0168.68FALSE00
2025-10-172.50PUT0 0172.05FALSE00
2025-10-1750.54PUT32 35142.79FALSE0.040.08
2025-10-177.51.95PUT2460 36153.2TRUE1.950
2025-10-17100PUT0 0148.97TRUE00
2025-10-1712.50PUT0 0181.71TRUE00
2025-10-17150PUT0 0248.74TRUE00
2025-11-212.54.55CALL2 092.07TRUE4.550
2025-11-2152.65CALL0 59114.98TRUE00
2025-11-217.51.95CALL0 136144.67FALSE00
2025-11-21101.15CALL3 52153.09FALSE1.150
2025-11-2112.50.85CALL10 672147.77FALSE00
2025-11-21150.7CALL0 44141.76FALSE00
2025-11-2117.50CALL0 0157.78FALSE00
2025-11-212.50.18PUT0 13161.45FALSE00
2025-11-2151.1PUT73 274170.34FALSE0.10.1
2025-11-217.52.55PUT25 1039166.19TRUE0.050.02
2025-11-21104.6PUT22 55180.22TRUE0.10.02
2025-11-2112.56.11PUT0 50179.08TRUE00
2025-11-21150PUT0 0187.25TRUE00
2025-11-2117.50PUT0 0177.31TRUE00
2025-12-192.54.95CALL0 9165.32TRUE00
2025-12-1953.84CALL0 3020106.67TRUE00
2025-12-197.52.1CALL0 2606157.54FALSE00
2025-12-19101.95CALL0 2728163.27FALSE00
2025-12-1912.51.4CALL2 1800164.51FALSE0.150.12
2025-12-19151.1CALL2 1600164.5FALSE1.10
2025-12-1917.50.85CALL10 1732162.4FALSE-0.1-0.11
2025-12-19200.75CALL3 2173167.19FALSE0.750
2025-12-1922.50.75CALL0 158145.48FALSE00
2025-12-19250.47CALL0 475148.51FALSE00
2025-12-192.50.3PUT0 1127180.74FALSE00
2025-12-1951.35PUT75 3028171.98FALSE-0.05-0.04
2025-12-197.52.93PUT0 1076176.85TRUE00
2025-12-19104.9PUT0 2214190.65TRUE00
2025-12-1912.57.1PUT0 288196.05TRUE00
2025-12-19159.45PUT5 88197.98TRUE0.150.02
2025-12-1917.510.05PUT0 507195.34TRUE00
2025-12-19200PUT0 0188.9TRUE00
2025-12-1922.50PUT0 0189.77TRUE00
2025-12-19250PUT0 0203.57TRUE00
2026-01-162.54.7CALL0 17147.68TRUE00
2026-01-1653.2CALL1 202135.74TRUE-0.14-0.04
2026-01-167.52.55CALL10 4732155.19FALSE0.150.06
2026-01-16101.96CALL118 2980155.7FALSE-0.04-0.02
2026-01-1612.51.7CALL0 528160.47FALSE00
2026-01-16151.43CALL6 1073166.9FALSE0.180.14
2026-01-1617.51.05CALL0 475156.82FALSE00
2026-01-16200.8CALL0 967156.87FALSE00
2026-01-1622.50.75CALL12 308159.44FALSE0.750
2026-01-16250.6CALL12 98156.6FALSE0.60
2026-01-16300.45CALL0 4211157.39FALSE00
2026-01-162.50.39PUT0 437139.05FALSE00
2026-01-1651.62PUT124 800177.47FALSE0.020.01
2026-01-167.53.5PUT10 694192.11TRUE3.50
2026-01-16105.05PUT0 1525181.53TRUE00
2026-01-1612.57.76PUT0 1716244.87TRUE00
2026-01-16159.77PUT0 347185.58TRUE00
2026-01-1617.50PUT0 197186.52TRUE00
2026-01-162014.9PUT0 250187.45TRUE00
2026-01-1622.50PUT0 0182.99TRUE00
2026-01-16250PUT0 0182.76TRUE00
2026-01-163020.9PUT0 48147.62TRUE00
2026-03-202.55.1CALL0 1152.42TRUE00
2026-03-2053.3CALL6 31119.41TRUE3.30
2026-03-207.52.5CALL0 263130.57FALSE00
2026-03-20102.12CALL0 278140.09FALSE00
2026-03-2012.51.72CALL0 51106.46FALSE00
2026-03-20151.55CALL0 1109.36FALSE00
2026-03-2017.51.1CALL1 1134.68FALSE1.10
2026-03-202.50PUT0 0151.94FALSE00
2026-03-2051.95PUT2 6173.05FALSE1.950
2026-03-207.50PUT0 0162.4TRUE00
2026-03-20105.4PUT0 20181.58TRUE00
2026-03-2012.50PUT0 0172.71TRUE00
2026-03-20150PUT0 0169.83TRUE00
2026-03-2017.50PUT0 0168.73TRUE00
2027-01-152.54.85CALL0 1596100.43TRUE00
2027-01-1554CALL0 1018156.62TRUE00
2027-01-157.53.13CALL0 2663115.34FALSE00
2027-01-15103.07CALL0 749109.55FALSE00
2027-01-1512.52.6CALL0 55383.49FALSE00
2027-01-15152.25CALL0 1352106.63FALSE00
2027-01-1517.52CALL0 122793.66FALSE00
2027-01-15201.85CALL0 180133.99FALSE00
2027-01-1522.51.8CALL0 131139.22FALSE00
2027-01-15251.35CALL0 772144.5FALSE00
2027-01-15301CALL0 1088110.48FALSE00
2027-01-152.50.9PUT0 140133.39FALSE00
2027-01-1552.7PUT5 74153.29FALSE2.70
2027-01-157.54.15PUT0 84116.27TRUE00
2027-01-15106.2PUT0 118157.47TRUE00
2027-01-1512.58.3PUT0 339152.9TRUE00
2027-01-15150PUT0 14148.67TRUE00
2027-01-1517.511.46PUT0 1146.66TRUE00
2027-01-152014PUT0 54146.79TRUE00
2027-01-1522.50PUT0 0133.3TRUE00
2027-01-152519.79PUT0 40144.26TRUE00
2027-01-153024.7PUT0 11132.59TRUE00

Latest CAPR Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST62$3.88
Jun 13, 2022 7:58 PM EST5$3.8
Jun 13, 2022 7:59 PM EST100$3.8
Jun 13, 2022 7:59 PM EST100$3.79
Jun 13, 2022 7:59 PM EST50$3.79

Capricor Therapeutics, Inc (CAPR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000018034036/0000000000-18-034036-index.htm
2019-12-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000019016215/0000000000-19-016215-index.htm
2020-05-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000020004293/0000000000-20-004293-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133869/000091957419007837/0000919574-19-007837-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919061080/0001104659-19-061080-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919061773/0001104659-19-061773-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919063785/0001104659-19-063785-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919064252/0001104659-19-064252-index.htm
2019-12-05S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919070066/0001104659-19-070066-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072396/0001104659-19-072396-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072626/0001104659-19-072626-index.htm
2019-12-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465919072629/0001104659-19-072629-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073161/0001104659-19-073161-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073600/0001104659-19-073600-index.htm
2019-12-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919074049/0001104659-19-074049-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074247/0001104659-19-074247-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022098/0001104659-20-022098-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/0001104659-20-022099-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/0001104659-20-022100-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022101/0001104659-20-022101-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022102/0001104659-20-022102-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022103/0001104659-20-022103-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022104/0001104659-20-022104-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022105/0001104659-20-022105-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022110/0001104659-20-022110-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920031538/0001104659-20-031538-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920034994/0001104659-20-034994-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920035320/0001104659-20-035320-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920038468/0001104659-20-038468-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000110465920039272/0001104659-20-039272-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920047790/0001104659-20-047790-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920056292/0001104659-20-056292-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920056303/0001104659-20-056303-index.htm
2020-05-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465920058189/0001104659-20-058189-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920058192/0001104659-20-058192-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060449/0001104659-20-060449-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060930/0001104659-20-060930-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920061570/0001104659-20-061570-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062419/0001104659-20-062419-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062458/0001104659-20-062458-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920062698/0001104659-20-062698-index.htm
2020-05-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920063822/0001104659-20-063822-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920066994/0001104659-20-066994-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071410/0001104659-20-071410-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071413/0001104659-20-071413-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071415/0001104659-20-071415-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071417/0001104659-20-071417-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071419/0001104659-20-071419-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071420/0001104659-20-071420-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071421/0001104659-20-071421-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071423/0001104659-20-071423-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071426/0001104659-20-071426-index.htm
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920091413/0001104659-20-091413-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920092415/0001104659-20-092415-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920098381/0001104659-20-098381-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2017-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053252/0001144204-17-053252-index.htm
2017-10-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417053253/0001144204-17-053253-index.htm
2017-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2017-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417057263/0001144204-17-057263-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417058512/0001144204-17-058512-index.htm
2017-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417059277/0001144204-17-059277-index.htm
2017-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417061266/0001144204-17-061266-index.htm
2017-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417063248/0001144204-17-063248-index.htm
2017-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417064330/0001144204-17-064330-index.htm
2017-12-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417065088/0001144204-17-065088-index.htm
2018-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000266/0001144204-18-000266-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000853/0001144204-18-000853-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000854/0001144204-18-000854-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000856/0001144204-18-000856-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000857/0001144204-18-000857-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000859/0001144204-18-000859-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000860/0001144204-18-000860-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000861/0001144204-18-000861-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000862/0001144204-18-000862-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000863/0001144204-18-000863-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000864/0001144204-18-000864-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000865/0001144204-18-000865-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2018-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418005594/0001144204-18-005594-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418009043/0001144204-18-009043-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014063/0001144204-18-014063-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014635/0001144204-18-014635-index.htm
2018-03-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420418016468/0001144204-18-016468-index.htm
2018-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418022479/0001144204-18-022479-index.htm
2018-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418025173/0001144204-18-025173-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418027107/0001144204-18-027107-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418027786/0001144204-18-027786-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418033770/0001144204-18-033770-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418039922/0001144204-18-039922-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418043267/0001144204-18-043267-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418043686/0001144204-18-043686-index.htm
2018-10-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420418055035/0001144204-18-055035-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418056889/0001144204-18-056889-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418059340/0001144204-18-059340-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418059980/0001144204-18-059980-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418066148/0001144204-18-066148-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419000167/0001144204-19-000167-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419002173/0001144204-19-002173-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419005129/0001144204-19-005129-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419016629/0001144204-19-016629-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419016787/0001144204-19-016787-index.htm
2019-04-0110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419017194/0001144204-19-017194-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419020402/0001144204-19-020402-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419022029/0001144204-19-022029-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419025600/0001144204-19-025600-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419026041/0001144204-19-026041-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029338/0001144204-19-029338-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029669/0001144204-19-029669-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419031589/0001144204-19-031589-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034627/0001144204-19-034627-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034690/0001144204-19-034690-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034770/0001144204-19-034770-index.htm
2019-07-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420419034954/0001144204-19-034954-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419035262/0001144204-19-035262-index.htm
2019-07-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419035263/0001144204-19-035263-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419037875/0001144204-19-037875-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419038387/0001144204-19-038387-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038994/0001144204-19-038994-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038995/0001144204-19-038995-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038996/0001144204-19-038996-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038997/0001144204-19-038997-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038998/0001144204-19-038998-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038999/0001144204-19-038999-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039000/0001144204-19-039000-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039001/0001144204-19-039001-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419040654/0001144204-19-040654-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419042160/0001144204-19-042160-index.htm
2019-08-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419042161/0001144204-19-042161-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419047446/0001144204-19-047446-index.htm
2019-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519001637/9999999995-19-001637-index.htm
2019-12-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519002841/9999999995-19-002841-index.htm
2020-05-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999520001205/9999999995-20-001205-index.htm
2018-04-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718004982/9999999997-18-004982-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718007502/9999999997-18-007502-index.htm

Capricor Therapeutics, Inc (CAPR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Capricor Therapeutics, Inc (CAPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 253%
Institutional Ownership: 620%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-10-23Louis ManzoDirectorBuy20,748.000.163,319.68159,132.00https://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2019-12-17Frank LitvackDirectorBuy20,391.0020,391.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2017-12-22Rachel SmithVice President of R&DBuy20,748.000.163,319.6820,748.00https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2019-12-17David B MusketDirectorBuy20,391.0022,891.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-17Louis ManzoDirectorBuy20,391.0036,304.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2020-09-24Louis ManzoDirectorBuy8,299.003.7030,706.3044,603.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2020-07-27Linda MarbanCHIEF EXECUTIVE OFFICERBuy41,497.003.70153,538.9062,367.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm